Health Dictionary Find a Doctor

Splenic vein thrombosis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Vindhya BellamKonda, M.B.B.S [2]Sunny Kumar MD [3]

Overview

Overview

Medical therapy for splenic vein thrombosis include anticoagulation to maintain INR between 2 to 3. The goal of anticoagulation is to prevent extension of the clot and to allow for recanalization so that intestinal infarction and portal hypertension do not develop. The mainstay of therapy in splenic vein thrombosis with gastric varices is sclerotherapy and gastric banding.

Medical therapy

Medical therapy

Medical therapy for splenic vein thrombosis include anticoagulation to maintain INR between 2 to 3. The goal of anticoagulation is to prevent extension of the clot and to allow for recanalization so that intestinal infarction and portal hypertension do not develop. The mainstay of therapy in splenic vein thrombosis with gastric varices is sclerotherapy and gastric banding.[1][2][3][4][5]

References

References

  1. Bouvier A, Gout M, Audia S, Chalumeau C, Rat P, Deballon O (2017). “[Routine screening of splenic or portal vein thrombosis after splenectomy]”. Rev Med Interne (in French). 38 (1): 3–7. doi:10.1016/j.revmed.2016.08.003. PMID 27639911.
  2. Valla D (2015). “Splanchnic Vein Thrombosis”. Semin Thromb Hemost. 41 (5): 494–502. doi:10.1055/s-0035-1550439. PMID 26080307.
  3. Gouin B, Robert-Ebadi H, Casini A, Beauverd Y, Fontana P, Righini M; et al. (2017). “[Splanchnic vein thrombosis]”. Rev Med Suisse. 13 (586): 2138–2143. PMID 29211374.
  4. Riva N, Ageno W (2017). “Approach to thrombosis at unusual sites: Splanchnic and cerebral vein thrombosis”. Vasc Med. 22 (6): 529–540. doi:10.1177/1358863X17734057. PMID 29202678.
  5. Riva N, Donadini MP, Dentali F, Squizzato A, Ageno W (2012). “Clinical approach to splanchnic vein thrombosis: risk factors and treatment”. Thromb Res. 130 Suppl 1: S1–3. doi:10.1016/j.thromres.2012.08.259. PMID 23026649.
  6. Henao EA, Bohannon WT, Silva MB (2003). “Treatment of portal venous thrombosis with selective superior mesenteric artery infusion of recombinant tissue plasminogen activator”. J. Vasc. Surg. 38 (6): 1411–5. doi:10.1016/S0741. PMID 14681650.
  7. 7.0 7.1 Tateishi A, Mitsui H, Oki T, Morishita J, Maekawa H, Yahagi N, Maruyama T, Ichinose M, Ohnishi S, Shiratori Y, Minami M, Koutetsu S, Hori N, Watanabe T, Nagawa H, Omata M (2001). “Extensive mesenteric vein and portal vein thrombosis successfully treated by thrombolysis and anticoagulation”. J. Gastroenterol. Hepatol. 16 (12): 1429–33. PMID 11851847.

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH